Wells Fargo Upgrades West Pharmaceutical (WST) to Outperform
- Wall Street again marks new highs in post-election run
- Broadcom Ltd. (AVGO) Tops Q4 EPS by 11c
- Restoration Hardware (RH) Tops Q3 EPS by 4c; Guides Well Below the Street
- Unusual 11 Mid-Day Movers 12/8: (COOL) (TLRD) (DRAM) Higher; (SHIP) (OHRP) (MLSS) Lower
- After-Hours Stock Movers 12/08: (FNSR) (AVGO) (GLPG) Higher; (XTLY) (RH) (DLTH) Lower (more...)
Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.
Wells Fargo upgraded West Pharmaceutical (NYSE: WST) from Market Perform to Outperform.
Shares of West Pharmaceutical closed at $72.42 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Mizuho Securities Upgrades Lululemon Athletica Inc. (LULU) to Buy; Sees Upside Continuing
- JPMorgan Upgrades Credit Suisse (CS) to Overweight
- UPDATE: Oppenheimer Upgrades Envision Healthcare (EVHC) to Outperform